NORDIC REGIONAL OFFICE

Gilead Sciences Sweden AB
Solna Gate
Hemvarnsgatan 9
171 54
Solna
Sweden

Phone: 46 8 5057 1800

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead's operation in Sweden is responsible for sales and marketing support for Gilead’s products throughout the country.

Transparency Reporting

In line with local Transparency Reporting requirements, Gilead is disclosing its interactions with HealthCare Professionals and HealthCare Organizations in Sweden in the following report, supported by a Methodological Note. Enquiries about the report should be directed to: http://www.gilead.com/news/media-inquiries










Relationships with Charitable Organizations

Gilead provided support for the following charitable organizations in 2015, via unrestricted educational grants. The information is correct at the time of writing (March 2016). The information is subject to change and will be updated accordingly. For a listing of previous years' grants, click here

  • Grant Recipient
    Description of Activity
    Amount Funded SEK
  • HIV Sweden
    Awareness documentary project : Film project "Resan"
    65625
  • HIV Sweden
    25th Anniversary 2015
    18000
  • HIV Sweden
    HIV and Your Quality of Life 4-5 Sept 2015
    2970
  • Noaks Ark Syd
    Follow up on book "Ophelia's journey"
    50000
  • Noaks Ark Syd
    Autumn Campaign 2015
    60000
  • Noaks Ark Syd
    HIV-testing and treatment campaign during the European Testing week
    50000
  • Noaks Ark Syd
    World AIDS Day 2015 seminar
    50000
  • Noaks Ark, Stockholm
    World AIDS Day 2015 seminar
    24550
  • Noaks Ark
    HIV and Your Quality of Life 4-5 Sept 2015
    5170
  • Noaks Ark, Småland och Halland
    HIV and Your Quality of Life 4-5 Sept 2015
    4797
  • Positiva Gruppen Väst
    HIV and Your Quality of Life 4-5 Sept 2015
    2970
Language:


This page is intended for visitors outside of the United States.